The incidence of gastric cancer is much higher in Japan than in other count
ries even though diagnostics and treatments of such patients have improved.
The objective of this study was to present an overview of the past. presen
t and future of surgical treatment for our patients with gastric cancer. We
analysed data on 2152 Japanese men and women with gastric cancer who under
went surgical resection from 1965 to 1995 at Kyushu University in Fukuoka,
Japan, based on a univariate and the multivariate analysis. We focused on t
ime trends of surgical treatment and the postoperative outcome. Over the ye
ars, there have been favourable changes in the numbers of patients with ear
ly gastric cancer, in all cases of gastric cancer; the rate of 18% in the f
irst six year period (group 1) was 57% in the last 5 year period (group 6).
Size of the tumour was smaller. well-differentiated tumour tissue was more
common, and lymphatic involvement was less frequent. Lymph node metastasis
, liver metastasis and peritoneal dissemination all decreased. Extensive ly
mph node dissection was more frequently done and the rate of curative resec
tion (curability A and B) increased. With increases in identifying the earl
y stage of cancer and better perioperative care, mortality rates 30 days af
ter the surgery greatly decreased. Multivariate analysis revealed that the
10 factors of depth of invasion, lymph node metastasis, lymph node dissecti
on, tumour size, liver metastasis, peritoneal dissemination, lymphatic inva
sion, Vascular invasion, lesion in the whole stomach and lesion in the midd
le stomach were independent factors for determining the prognosis. Detectio
n of the tumour in an early stage, standardized surgical treatment, includi
ng routine lymph node dissection, close follow-up schedules and better peri
operative management are expected to increase survival time for patients wi
th this malignancy. (C) 2000 Cancer Research Campaign.